<< Вернуться к списку статей журнала

Том 6 №2 2004 год - Нефрология и диализ

Туберкулез у больных с терминальной хронической почечной недостаточностью (Обзор литературы)

Агафонова С.Г. Прокопенко Е.И.

Аннотация: Туберкулез у больных терминальной хронической почечной недостаточностью (ТХПН), особенно у реципиентов почечных трансплантатов, получающих постоянную медикаментозную иммуносупрессию, является серьезным, часто угрожающим жизни заболеванием

Для цитирования: Агафонова С.Г., Прокопенко Е.И. Туберкулез у больных с терминальной хронической почечной недостаточностью (Обзор литературы). Нефрология и диализ. 2004. 6(2):108-116. doi:

Весь текст

Ключевые слова: туберкулез, хроническая почечная недостаточность, трансплантация почки

Список литературы:

1. Аленова А.Х. Информативность полимеразной цепной реакции в диагностике туберкулезного процесса. Проблемы туберкулеза 2002; 1: 45-46.
2. Борисов С.Е. Диагностика туберкулеза: возможности и пределы. Проблемы туберкулеза 2001; 3: 5-9.
3. Ватазин А.В., Прокопенко Е.И., Щербакова Е.О. и др. Особенности диагностики туберкулеза у больных хронической почечной недостаточностью на программном гемодиализе и после трансплантации почки. Нефрология и диализ 1999; 1 (1): 39-44.
4. Воробьев П.А., Колендо С.Е., Дворецкий Л.И. и др. Туберкулез у больных с хронической почечной недостаточностью. Тер. архив 1996; 68: 68-71.
5. Денисова Т.С., Говорун В.М., Бочкарев Е.Г. Возможность применения полимеразной цепной реакции (ДНК-диагностика) при выявлении микобактерий туберкулезного комплекса. Проблемы туберкулеза 1999; 6: 54-55.
6. Карачунский М.А. Туберкулез в наши дни. РМЖ 2001; 9 (21): 951-953.
7. Лазарева Я.В. Современная диагностика туберкулеза. Пульмонология 1999; 4: 67.
8. Лечение хронической почечной недостаточности. Под ред. С.И. Рябова. СПб.: 1997: 448.
9. Перлин Д.В. Дифференциальная диагностика, лечение и профилактика осложнений при трансплантации почки: Автореф. дисс. … док. мед. наук. 1998: 43.
10. Перлин Д.В., Даренков С.П., Старостенко Е.В. и др. Генерализованый туберкулез после трансплантации почки. Урология 1999; 5: 26-28.
11. Рекомендации по лечению резистентных форм туберкулеза. ВОЗ. Женева: 1998.
12. Хоменко A.H. Современные тенденции распространения туберкулеза в России. РМЖ 1998; 6 (17).
13. Черноусова Л.Н. Современные тенденции и возможности микробиологической диагностики туберкулеза. РМЖ 2002; 10 (16): 697-698.
14. Черноусова Л.Н., Ларионова Е.Е., Севастьянова Э.В., Голышевская В.И. Роль ПЦР-анализа в комплексных бактериологических исследованиях во фтизиатрии. Проблемы туберкулеза 2001; 3: 58-60.
15. Шилова М. Организация и результаты лечения больных туберкулезом в России. Врач 2001; 2: 3-7.
16. Aguado J.M., Herrero J.A., Gavalda J. et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group. GESITRA. Transplantation 1997; 63 (9): 1278-1286.
17. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000; 49: 1-51.
18. Antony S.J., Ynares C., Dummer J.S. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant 1997; 11 (1): 34-37.
19. Apaydin S., Altiparmak M.R., Serdengecti K. et al. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 2000; 32 (5): 501-505.
20. Biz E., Pereira C.A., Moura L.A. et al. The use of cyclosporine modifies the clinical and histopathological presentation of tuberculosis after renal transplantation. Rev Inst Med Trop Sao Paulo 2000; 42 (4): 225-230.
21. Buffinglon G.A., Dominguez J.H., Piering W.F. et al. Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. J Am Med Assoc 1976; 236: 1958-1960.
22. Chenhsu R.Y., Loong C.C., Chou M.H. et al. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacother 2000; 34 (1): 27-31.
23. Costa Nascimento J.M., Meyers A.M., Botha J.R., Conlan A.A. Myhurgh Mycobacterial infection in recipients of kidney allografts. A seventeen-year experience. Ada Med Port 1988; 1: 51-57.
24. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002; 17 Suppl 4: 39-43.
25. Espinal M.A., Laszlo A., Simonsen L. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Eng J A W 2001; 344: 1294-1303.
26. Fadda G., Grillo R., Ginesu F. et al. Serodiagnosis and follow up of patients with pulmonary tuberculosis by enzyme-linked immunosorbent assay. Eur J Epidemiol 1992; 8: 81-87.
27. Farooqui M.A., Berenson C., Lohr J.W. Mycobacterium marinum infection in a renal transplant recipient. Transplantation 1999; 67 (11): 1495-1496.
28. Garcia-Leoni M.E., Martin-Scapa C., Rodeno P., Valderrabano F., Moreno S., Bouza E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990; 9: 283-285.
29. Graham J.C., Kearns A.M., Magee J.G. Tuberculosis transmitted through transplantation. Infect 2001; 43 (4): 251-254.
30. Gulati M., Kaur R., Jha V. et al. High-resolution CT in renal transplant patients with suspected pulmonary infections. Acta Radiol 2000; 41 (3): 237-241.
31. Hall C.M., Wilcox P.A., Swanepoel C.R. et al. Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435-439.
32. Held P.J., Levin N.W., Pauly M.V., Diamond L.H. Mortality and duration of hemodialysis treatment. J A V A 1991; 265: 871.
33. Higgins R.M., Cahn A.P., Porter D. Mycobacterial infections after renal transplantation. Q J M 1991; 78: 145-153.
34. Ho K.J. Galloping caseous pneumonia with miliary dissemination in a renal transplant recipient: emphasis on pretransplant detection and prophylaxis. Nephron 1992; 62: 363-364.
35. Jereb J.A., Burwen D.R., Dooley S.W. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis 1993; 168 (5): 1219-1224.
36. Jha V., Kohli H.S., Sud K. et al. Laryngeal tuberculosis in renal transplant recipients. Transplantation 1999; 68 (1): 153-155.
37. Jha V., Sakhuja V., Gupta D. et al. Successful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int 1999; 56 (5): 1944-1950.
38. John G.T., Shankar V., Abraham A.M. et al. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1145-1148.
39. John G.T., Thomas P.P., Thomas M. et al. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57: 1683-1684.
40. Kisielnicka E., Sulima-Gillow A., Rutkowski B. Bone tuberculosis in a hemodialyzed patient - a difficult diagnostic problem. Pol Arch Med Wewn 1994; 92 (3): 266-269.
41. Klemperer J.D., Wang J., Hartman B.J., Stubenbord W.T. Mycobacterium tuberculosis infection of a native polycystic kidney following renal transplantation. Transplantation 1998; 66 (1): 118-120.
42. Kopanoff D.E., Snider D.E.Jr., Caras G.J. Isoniazid-relaled hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117: 991-1001.
43. Korzets A., Gafter U. Tuberculosis prophylaxis for the chronically dialysed patient - yes or no? Nephrol Dial Transplant 1999; 14: 2857-2859.
44. Koselj M., Buturovic J., Malovrh M. Tuberculosis in renal allograft recipients. Transplant Proc 1992; 24: 1909-1910.
45. Kukrej N., Cook G.J., Pattison J.M. et al. Positron-emission tomography used to diagnose tuberculosis in a renal transplant patient. Am J Transplant 2002; 2 (1): 105-107.
46. Lezaic V., Radivojevic R., Radosavljevic G. et al. Does tuberculosis after kidney transplantation follow the trend of tuberculosis in general population? Ren Fail 2001; 23 (1): 97-106.
47. Lorimer I., Botha J., Pontin A.R. et al. Tuberculosis isolated to the renal allograft. Transpl Infect Dis 1999; 1 (1): 83-86.
48. Mat O., Abramowicz D., Peny M.O. et al. Tuberculosis presenting as acute hepatitis in a renal transplant recipient. Transpl Int 1994; 7 (1): 67-69.
49. Millard P.S., Wilcosky T.C., Reade-Christopher S.J., Weber D.J. Isoniazid-related fatal hepatitis. West J Med 1996; 164 (6): 486-491.
50. Mohamed A.J., Sathiyaraj D., Muthu R. et al. Detection of antibodies against cell wall-associated antigens of Mycobacterium tuberculosis (SIHV) by an enzyme linked immunosorbent assay. Jpn J Med Sci Biol 1997; 8: 1-7.
51. Motiwala H.G., Sanghvi N.P., Barjatiya M.K., Patel S.M. Syndrome of inappropriate antidiuretic hormone following tuberculous epididymo-orchitis in renal transplant recipient: case report. J Urol 1991; 146 (5): 1366-1367.
52. Mourad G., Soulillou J.P., Chong G., Pouliqucn M., Hourmant M., Mion C. Transmission of Mycobacterium tuberculosis with renal allografts. Nephron 1985; 41: 82-85.
53. Mrowka C., Heintz B., Reul J., Sieberth H. Cerebral tuberculoma 11 years after renal transplantation. Am J Nephrol 1998; 18 (6): 557-559.
54. Naqvi A., Akhtar F., Naqvi R. Problems of diagnosis and treatment of tuberculosis following renal transplantation. Transplant Proc 1997; 29: 3051-3052.
55. Naqvi S.A., Hussain M., Askari H. et al. Is there a place for prophylaxis against tuberculosis following renal transplantation. Transplant Proc 1992; 24: 1912.
56. Nolan C.M., Goldberg S.V., Buskin S.F. et al. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. J Am Med Assoc 1999; 281: 1014-1018.
57. Offermann G., Keller F., Molzahn M. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment. Am J Nephrol 1985; 5: 385-387.
58. Oh C.S., Stratta R.J., Fox B.C. et al. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation 1988; 45 (1): 68-73.
59. Ozdemir F.N., Guz G., Kayatas M. Tuberculosis remains an important factor in the morbidity and mortality of hemodialysis patients. Transplant Proc 1998; 28: 846-847.
60. Park K.W., Kim U.S., Shin J.W. et al. Disseminated erythematous papules in a renal transplant recipient: a case of disseminated tuberculosis. Scand J Infect Dis 2002; 34 (10): 775-777.
61. Park S.B., Joo I., Suk J., Clio W.H., Park C.H., Kim H.C. Clinical manifestations of tuberculosis in renal transplant patients. Transplant Proc 1996; 28: 1520-1522.
62. Peces R., Pobes A., Diaz-Corte C., Gago E. Hypercalcemia, inappropriate calcitriol levels, and tuberculosis on hemodialysis. Scand J Urol Nephrol 2000; 34 (4): 287-288.
63. Perelman M. Tuberculosis in Russia. Int J Tuberc Lung Dis 2000; 4 (12): 1097-1103.
64. Peschke B., Ernst W., Gossmann J. et al. Antituberculous drugs in kidney transplant recipients treated with cyclosporine. Transplantation 1993; 56: 236-238.
65. Peters T.O., Reiter C.G., Boswell R.L. Transmission of tuberculosis by kidney transplantation. Transplantation 1984; 38: 514-516.
66. Qunibi W.Y., al-Sibai M.B., Taher S. Mycobacterial infection after renal transplantation - report of 14 cases and review of the literature. Q J Med 1990; 63: 1039-1060.
67. Raviglione M.C., O’Brien R.J. In: Fauci A., Braunwald E., Isselbacher K.J. et al. eds. Harrison’s Principles of Internal Medicine. 14th ed. McGraw Hill. New York: 1998; 1004-1014.
68. Rose D.N. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch intern Meet 2000; 160: 1513-1521.
69. Rubin R.H. Fungal and bacterial infections in the immunocompromised host Eur J Clin Microbiol Infect Dis 1993; 12 Suppl 1: S42-48.
70. Ruiz L.A., Gil P., Zalacain R. et al. Usefulness of bronchoalveolar lavage in the renal transplant patient with suspected respiratory infection. Arch Bronconeumol 1998; 34 (8): 388-393.
71. Sakhuja V., Jha V., Varma P.P., Joshi K., Chugh K.S. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
72. Samhan M., Panjwani D.D., Dadah S.K. et al. Is tuberculosis contraindication for renal transplantation? Transplant Proc 1989; 21: 2036-2038.
73. Schom T.F., Merscher S., Franz A. et al. Disseminated tuberculosis after renal transplantation. Transpl Int 1990; 3: 113-115.
74. Shab M., Shabtai E., Waltzer W. et al. Principal component analysis of blood lymphocyte subsets - an assesment of intersubset relationships. Transplantation 1991; 51 (5): 1135-1137.
75. Shollmeyer P., Bozkurt F. The immune status of uremic patients: hemodialysis vs CAPD. Clin Nephrol 1988; 30 (Suppl 1): 37-40.
76. Singh N., Paterson D.L. Mycobaclerium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Disease 1998; 27: 1266-1277.
77. Smirnoff M., Patt C., Seckler B., Adler J.J. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998; 113: 25-27.
78. Sud K., Muthukumar T., Singh B. et al. Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients. Methods Find Exp Clin Pharmacol 2000; 22 (8): 647-649.
79. Suleiman A.B., Musa Z., Morad Z. Tuberculosis in living related donor renal transplant recipients. Singapore: Ann Acad Med 1988; 17: 454-456.
80. Tarng D.C., Su W.J., Huang T.P. et al. PCR diagnosis on formalin-fixed, paraffin-embedded tissues with acid-fast stain and culture negativity in chronic dialysis patients of cervico-mediastinal tuberculous lymphadenitis. Nephrol Dial Transplant 1998; 13: 1543-1546.
81. Tham S.N., Choong H.L. Primary tuberculous chancre in a renal transplant patient. J Am Acad Dermatol 1992; 26 (2 Pt 2): 342-344.
82. Thomas P.A.Jr., Mozcs M.F., Jonasson O. Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients. Arch Surg 1979; 114: 597-599.
83. Tolkoff-Rubin N.E., Rubin R.H. Recent advances in the diagnosis and management of infection in the organ transplant recipient. Semin Nephrol 2000 Mar; 20 (2): 148-163.
84. Vachharajani T., Abreo K., Phadke A. et al. Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients. Am J Nephrol 2000; 20 (4): 273-277.
85. Waiser J., Schotschel R., Budde K., Neumayer H.H. Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation. Am J Kidney Dis 2000; 35 (3): E12.
86. Woeltje K.F., Mathew A., Rothstein M. et al. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 1998; 31 (5): 848-852.
87. Yang C.W., Lee J.H., Kim Y.G. et al. Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient: case report and review of the literature. Nephron 1996; 72 (4): 690-692.
88. Zambardi G., Druetta A., Roure C. et al. Rapid diagnosis of Mycobacterium tuberculosis infections by an ELISA-like detection of polymerase chain reaction products. Mol Cell Probes 1995; 72: 91-99.

Другие статьи по теме

• Легочные инфекции у реципиентов ренального аллотрансплантата (Результаты одноцентрового исследования)
• Диагностика и лечение туберкулеза у больных с почечным аллотрансплантатом: одноцентровое ретроспективное исследование
• Трансплантация почки от живого родственного донора
• Вирусные гепатиты. Особенности в условиях заместительной терапии хронической почечной недостаточности